Exploring the Interface between Substance Use Disorders and other Forms of Psychopathology using Phenotypic and Genomic Approaches
Project Number1K01DA059657-01A1
Former Number1K01DA059657-01
Contact PI/Project LeaderPOORE, HOLLY
Awardee OrganizationRUTGERS BIOMEDICAL AND HEALTH SCIENCES
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
This K01 proposal integrates research and training to address gaps in our understanding of the associations
between substance use disorders (SUDs) and other forms of psychopathology. Extant research has
consistently demonstrated that SUDs share phenotypic and etiologic variance with other forms of
psychopathology, such as externalizing and internalizing. Despite this, most research into the classification and
etiology of SUDs treats them as isolated from each other and other forms of psychopathology. A clearer
understanding of the ways in which SUDs covary, both phenotypically and genetically, is essential to increase
specificity of SUD phenotypes, which can be used as targets in future research, and which can improve
classification and treatment in clinical settings. The overall goal of this award is to facilitate Dr. Poore’s
development as an independent scientist working at the intersection of psychiatric nosology,
statistical genetics, and translational science to uniquely equip her to address these research
questions. The proposed training integrates Dr. Poore’s background in clinical psychology and classification
of psychopathology with training in substance use, advanced statistical genetics methods, and translational
research skills. The following training objectives will be completed during the award period to accomplish these
goals: 1) training in the interface between SUDs and internalizing psychopathology; 2) training in
biological annotation of genetic variants and multi-ancestry statistical genetic methods; 3) integrating
basic and clinical research; and 4) gaining professional competencies essential for independence.The
research aims proposed in this K01 use multiple analytic approaches to understand the relationships between
substance use disorders and other forms of psychopathology and the extent to which better classification can
improve prediction of treatment response in a treatment seeking population. These analyses will rely on
several sources of data, including large, deeply phenotyped samples that include broad measures of
psychopathology and relevant outcomes, previously published genome-wide association studies of psychiatric
disorders, and data collected from individuals seeking treatment at the Rutgers University Behavioral Health
Center to accomplish the following aims: 1) Use advanced quantitative methods to model the phenotypic
overlap between SUDs and other forms of psychopathology; 2) Identify and characterize genetic
variants that influence SUDs and other forms of psychopathology; 3) Quantify the clinical utility of
phenotypic and genetic psychopathology clusters.
Public Health Relevance Statement
PROJECT NARRATIVE
The interface between substance use, externalizing, and internalizing disorders is complex and poorly
characterized, which limits efforts to identify causes, correlates, and treatments for substance use disorders
(SUDs). The training and research described in this proposal will integrate phenotypic classification of SUDs
with statistical genetics and translational science to better characterize the phenotypic and genetic
relationships among SUDs and other forms of psychopathology. This project has the potential to improve the
specificity of phenotypes used in future studies, aid in gene discovery of SUDs, and improve the clinical utility
of classification and gene-identification efforts for SUDs.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAwardBasic ScienceBehavioralBiologicalCharacteristicsClassificationClinicalClinical PsychologyClinical ResearchComplementComplexDataDevelopmentDiagnosticDimensionsDiseaseEtiologyFailureFoundationsFutureGenesGeneticGenetic AnnotationGenetic ModelsGenomic approachGoalsIndividualInvestigationLifeMeasuresMental disordersMentorsMethodsModelingOutcomePathway interactionsPatternPhenotypePopulationPrediction of Response to TherapyProfessional CompetencePsychopathologyPublishingResearchResearch PersonnelSamplingScientistSourceSpecificityStructureSubstance Use DisorderSymptomsTaxonomyTestingTrainingTraining SupportTranslational ResearchUniversitiesVariantassociated symptombehavior changebehavior predictionbehavioral healthcomorbiditydisease classificationgene discoverygenetic approachgenetic variantgenome wide association studyimprovedlongitudinal datasetmemberperson centeredskillssubstance usesubstance use treatmentsymptom clustertraittreatment adherencetreatment response
No Sub Projects information available for 1K01DA059657-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1K01DA059657-01A1
Patents
No Patents information available for 1K01DA059657-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1K01DA059657-01A1
Clinical Studies
No Clinical Studies information available for 1K01DA059657-01A1
News and More
Related News Releases
No news release information available for 1K01DA059657-01A1
History
No Historical information available for 1K01DA059657-01A1
Similar Projects
No Similar Projects information available for 1K01DA059657-01A1